Literature DB >> 27485062

Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.

Maciej Adler1, Licia Larocca2, Francesca M Trovato3, Heather Marcinkowski4, Yasmin Pasha4, Simon D Taylor-Robinson4.   

Abstract

BACKGROUND AND AIMS: There are limited data on the significance of liver stiffness measurements (LSM) by transient elastography in the upper extreme end of the measurable spectrum. This multicentre retrospective observational study evaluated the risk of hepatocellular carcinoma (HCC) in patients with LSM ≥20 kPa.
METHODS: 432 cirrhosis patients with LSM ≥20 kPa between June 2007 and October 2015 were retrospectively followed-up through electronic records.
RESULTS: A minimum 1-year follow-up was available for 278 patients (177 men; average age 57, range 18-84). LSM ranged from 20.0 to 75.0 kPa (mean 34.6 kPa). Cumulative incidences of HCC were 19 (6.8%), 30 (10.8%) and 41 (14.7%) at 1, 2 and 3 years, respectively. HCC was associated with age (p = 0.003), higher LSM (p = 0.005) and viral aetiology (p = 0.007). Patients were divided into 4 groups based on LSM at entry: 20-25 kPa (n = 74); 25-30 kPa (n = 62); 30-40 kPa (n = 75); >40 kPa (n = 67). Compared to the 20-25 kPa group, the 30-40 kPa group had a hazard ratio (HR) of 3.0 (95% CI, 1.1-8.3; p = 0.037), and the >40 kPa group had a HR of 4.8 (95% CI, 1.7-13.4; p = 0.003).
CONCLUSIONS: This study shows an association between LSM at the upper extreme and HCC risk. Physicians may find this beneficial as a non-invasive dynamic approach to assessing HCC risk in cirrhosis patients.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27485062      PMCID: PMC4972373          DOI: 10.1016/j.hpb.2016.05.005

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  35 in total

1.  Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Authors:  M Sasso; I Tengher-Barna; M Ziol; V Miette; C Fournier; L Sandrin; R Poupon; A-C Cardoso; P Marcellin; C Douvin; V de Ledinghen; J-C Trinchet; M Beaugrand
Journal:  J Viral Hepat       Date:  2011-10-13       Impact factor: 3.728

2.  Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study.

Authors:  Shahin Merat; Rasoul Sotoudehmanesh; Mehdi Nouraie; Masoumeh Peikan-Heirati; Sadaf G Sepanlou; Reza Malekzadeh; Masoud Sotoudeh
Journal:  Arch Iran Med       Date:  2012-07       Impact factor: 1.354

3.  Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?

Authors:  Diana Feier; Monica Lupsor Platon; Horia Stefanescu; Radu Badea
Journal:  J Gastrointestin Liver Dis       Date:  2013-09       Impact factor: 2.008

4.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

5.  Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; Anthony Wing-Hung Chan; Faiza Chermak; Paul Cheung-Lung Choi; Wassil Merrouche; Shirley Ho-Ting Chu; Sophie Pesque; Henry Lik-Yuen Chan; Victor de Lédinghen
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

Review 6.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

Review 8.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Scott Friedman; John Iredale; Massimo Pinzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

9.  Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.

Authors:  E Nguyen-Khac; D Chatelain; B Tramier; C Decrombecque; B Robert; J-P Joly; M Brevet; P Grignon; S Lion; L Le Page; J-L Dupas
Journal:  Aliment Pharmacol Ther       Date:  2008-08-14       Impact factor: 8.171

10.  Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.

Authors:  Ryota Masuzaki; Ryosuke Tateishi; Haruhiko Yoshida; Eriko Goto; Takahisa Sato; Takamasa Ohki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Naoya Kato; Hitoshi Ikeda; Shuichiro Shiina; Takao Kawabe; Masao Omata
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

View more
  7 in total

1.  Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.

Authors:  Luca Rinaldi; Maria Guarino; Alessandro Perrella; Pia Clara Pafundi; Giovanna Valente; Luca Fontanella; Riccardo Nevola; Barbara Guerrera; Natalina Iuliano; Michele Imparato; Alessio Trabucco; Ferdinando Carlo Sasso; Filomena Morisco; Antonio Ascione; Guido Piai; Luigi Elio Adinolfi
Journal:  Dig Dis Sci       Date:  2019-04-01       Impact factor: 3.199

2.  Lipid droplets disrupt mechanosensing in human hepatocytes.

Authors:  LiKang Chin; Neil D Theise; Abigail E Loneker; Paul A Janmey; Rebecca G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-28       Impact factor: 4.052

3.  Differential Imaging of Liver Tumors before and after Microwave Ablation with Electrode Displacement Elastography.

Authors:  Robert M Pohlman; James L Hinshaw; Timothy J Ziemlewicz; Meghan G Lubner; Shane A Wells; Fred T Lee; Marci L Alexander; Kelly L Wergin; Tomy Varghese
Journal:  Ultrasound Med Biol       Date:  2021-05-16       Impact factor: 3.694

4.  Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Yinghua Zhang; Chuanfang Wang; Hui Li; Yuanyuan Ding
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 5.  Proteoglycans as Mediators of Cancer Tissue Mechanics.

Authors:  Anna Barkovskaya; Alexander Buffone; Martin Žídek; Valerie M Weaver
Journal:  Front Cell Dev Biol       Date:  2020-11-30

Review 6.  Non-invasive tests for the prediction of primary hepatocellular carcinoma.

Authors:  Giovanni Marasco; Antonio Colecchia; Giovanni Silva; Benedetta Rossini; Leonardo Henry Eusebi; Federico Ravaioli; Elton Dajti; Luigina Vanessa Alemanni; Luigi Colecchia; Matteo Renzulli; Rita Golfieri; Davide Festi
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

7.  Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma.

Authors:  Youde Liu; Xiumei Wang; Jing Xiao; Jing Sun; Yinghua Zhang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.